Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Abbott Provides the Right Laboratory Solutions for Imperial College Healthcare

Published: Friday, November 30, 2012
Last Updated: Friday, November 30, 2012
Bookmark and Share
Abbott’s managed service contract provides trusts with a cost-effective, guaranteed service.

The Division of Infection and Immunity at Imperial College Healthcare NHS Trust is benefitting from a managed service contract with Abbott, ensuring an efficient and reliable service for one of Britain’s largest NHS trusts.

Consultant Virologist Mark Atkins explained: “The Trust has a catchment of almost 1.5 million people, and so it is vital that all our equipment functions as it should, or a backlog will quickly develop. We have been working with Abbott for many years, and we know we can rely on our ARCHITECT® platforms and other Abbott instruments to perform as expected. The full automation offered by these systems gives us the throughput and flexibility to deliver a high quality, efficient service for our clinicians; the lab simply wouldn’t work without them.”

“The benefits of our managed service contract were clearly demonstrated during the recent merger of microbiology, virology and immunology services into a single blood sciences group within the Trust. Our Abbott facilities manager was instrumental in this, co-ordinating the transfer of equipment so that it did not interrupt services or have an impact on patients. The Abbott team also helped us to develop more efficient combined workflows, listening to our needs and delivering solutions that matched our requirements. For example, we are now running syphilis assays on our ARCHITECT systems, meaning all antenatal samples can be run on a single analyzer, and we can also run a high performance HIV test on this platform.”

Rebecca Stalham, Marketing and Contracts Director at Abbott, added: “A managed service contract provides trusts with a cost-effective, guaranteed service, allowing laboratory staff to focus on high value work which ultimately leads to better patient care, and we are happy that this model is working so well for Imperial College Healthcare.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Gut Bacteria Older than Human Species
Some bacteria have lived in the human gut since before we were human, suggesting evolution could have a larger role inhuman bacterial makeup.
Evidence of Mosquito Transmitting Zika
A direct link between the Yellow fever mosquito and Zika transmission has been found following investigation into selective mosquito control.
Antibody-Based Drug for Multiple Sclerosis
New antibody-based drug paves the way for new strategies for controlling and treating multiple sclerosis.
Three-Drug Combinations Counter Antibiotic Resistance
Research shows that combinations of three different antibiotics can treat resistant bacteria, even if they are ineffective independently.
Mapping Zika’s Routes to Developing Fetus
UC researchers show how Zika virus travels from a pregnant woman to her fetus, and also identified a drug that could stop it.
Treating HIV with Cancer-Fighting Gene Shows Promise
A type of gene immunotherapy that has shown promising results against cancer could also be used against HIV.
Protein Teams Activate T-Cells
Caltech researchers have discovered T-cell genetic switching is controlled by four proteins acting in a multi-tiered fashion.
'Antigen-Presenting Cell' Defends Against Cancer
Through advanced imaging, researchers have identified cells that encourages increases in immune system cancer defences.
Zika Epidemic Likely to End Within Three Years
A team of scientists has predicted that the current Zika epidemic is likely to end within three years because there will be too few people left to infect.
Go-Between Immune Cell is Key to Priming the Body’s Fight Against Cancer
‘Antigen-presenting cell’ activates T cells by alerting them to the presence of tumors.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!